CTI BIOPHARMA CORP Business Finance Contracts & Agreements
125 Contracts & Agreements
- Exchange Agreements (6 contracts)
- Financing Agreements (6)
- Guarantee Agreements (1)
- Guaranty Agreements (1)
- Indenture Agreements (2)
- Loan Agreements (8)
- Note Agreements (2)
- Purchase Agreements (34)
- Registration Rights Agreements (5)
- Release Agreements (1)
- Repurchase Agreements (1)
- Security Agreements (3)
- Shareholders Agreements (4)
- Stock Agreements (6)
- Subscription Agreements (1)
- Underwriting Agreements (7)
- Waiver Agreements (1)
- Warrant Agreements (36)
- CTI BioPharma Corp. Amended and Restated 2007 Employee Stock Purchase Plan (Filed With SEC on June 3, 2022)
- Purchase and Sale Agreement, dated August 25, 2021, by and between CTI BioPharma Corp. and Drug Royalty III LP 2 (Filed With SEC on November 12, 2021)
- CTI BioPharma Corp. Amended and Restated 2007 Employee Stock Purchase Plan (Filed With SEC on June 7, 2021)
- Underwriting Agreement by and among the Company and the Representatives, dated as of March 31, 2021 (Filed With SEC on April 6, 2021)
- CTI BioPharma Corp. Stock Option Agreement (Inducement Form) (Filed With SEC on March 17, 2021)
- Form of Warrant to Purchase Common Stock, dated November 6, 2018, issued to consultant to the Registrant (Filed With SEC on March 13, 2019)
- First Amendment to Loan and Security Agreement, dated May 17, 2018, by and between Silicon Valley Bank and CTI BioPharma Corp (Filed With SEC on August 3, 2018)
- Waiver Agreement, dated January 19, 2018, by and between Silicon Valley Bank and the Registrant (Filed With SEC on March 7, 2018)
- Loan and Security Agreement, dated November 28, 2017, by and between CTI BioPharma Corp. and Silicon Valley Bank (Filed With SEC on November 28, 2017)
- Warrant to Purchase Stock, dated November 28, 2017, by and between CTI BioPharma Corp. and Life Science Loans II, LLC (Filed With SEC on November 28, 2017)
- Warrant to Purchase Stock, dated November 28, 2017, by and between CTI BioPharma Corp. and Silicon Valley Bank (Filed With SEC on November 28, 2017)
- Fifth Amendment to Loan and Security Agreement, dated August 4, 2017, by and among Hercules Technology Growth Capital, Inc. (and certain of its affiliates), CTI BioPharma Corp.... (Filed With SEC on November 7, 2017)
- Fourth Amendment to Shareholder Rights Agreement, dated as of 22, 2017, between the Company and Computershare Trust Company, N.A., as Rights Agent (Filed With SEC on September 26, 2017)
- 22,500 Shares CTI BioPharma Corp. Series N-3 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on June 9, 2017)
- FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 11, 2015)
- 55,000 Shares CTI BioPharma Corp. Series N-2 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on December 9, 2015)
- THIRD AMENDMENT TO SHAREHOLDER RIGHTS AGREEMENT (Filed With SEC on December 1, 2015)
- 50,000 Shares CTI BioPharma Corp. Series N-1 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on October 30, 2015)
- SUBSCRIPTION AGREEMENT (Filed With SEC on September 29, 2015)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 10, 2015)
- WARRANT AGREEMENT To Purchase Shares of the Common Stock of CTI Biopharma Corp. Dated as of June 9, 2015 (the Effective Date) (Filed With SEC on June 10, 2015)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 12, 2015)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 29, 2014)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 15, 2013)
- FORM OF SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 18, 2013)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 28, 2013)
- WARRANT AGREEMENT To Purchase Shares of the Common Stock of Cell Therapeutics, Inc. Dated as of March 26, 2013 (the Effective Date) (Filed With SEC on March 28, 2013)
- SECOND AMENDMENT TO SHAREHOLDER RIGHTS AGREEMENT (Filed With SEC on December 7, 2012)
- 60,000 Shares Cell Therapeutics, Inc. Series 17 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on October 11, 2012)
- FIRST AMENDMENT TO SHAREHOLDER RIGHTS AGREEMENT (Filed With SEC on September 4, 2012)
- Letter of Guarantee (Filed With SEC on August 2, 2012)
- FORM OF WARRANT WARRANT TOPURCHASE COMMON STOCK (Filed With SEC on August 1, 2012)
- ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF CELL THERAPEUTICS, INC. DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES 16 PREFERRED STOCK (Filed With SEC on June 5, 2012)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 5, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 31, 2012)
- FORM OF WARRANT WARRANT TOPURCHASE COMMON STOCK (Filed With SEC on May 31, 2012)
- ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF CELL THERAPEUTICS, INC. DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES [ ] PREFERRED STOCK (Filed With SEC on April 24, 2012)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 24, 2012)
- ASSET PURCHASE AGREEMENT between S*BIOPTE LTD. and CELL THERAPEUTICS, INC. Dated as of April 18, 2012 Table of Contents (Filed With SEC on April 24, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 14, 2011)
